Advanced

The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies

Engelfriet, C P ; Reesink, H W ; Mannucci, P M ; Gringeri, A ; Ingerslev, J ; Brettler, D B ; Mauser-Bunschoten, E P ; Negrier, C ; Berntorp, Erik LU and Smith, O P , et al. (2000) In Vox Sanguinis 78(4). p.256-257
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Vox Sanguinis
volume
78
issue
4
pages
256 - 257
publisher
Federation of European Neuroscience Societies and Blackwell Publishing Ltd
external identifiers
  • pmid:10970234
  • scopus:0033940503
ISSN
1423-0410
DOI
10.1046/j.1423-0410.2000.78402561.x
language
English
LU publication?
yes
id
4fb06119-56d7-46c3-bf02-521344adc410 (old id 1117540)
date added to LUP
2016-04-01 15:45:12
date last changed
2019-09-04 02:49:43
@article{4fb06119-56d7-46c3-bf02-521344adc410,
  author       = {Engelfriet, C P and Reesink, H W and Mannucci, P M and Gringeri, A and Ingerslev, J and Brettler, D B and Mauser-Bunschoten, E P and Negrier, C and Berntorp, Erik and Smith, O P and Shapiro, A D},
  issn         = {1423-0410},
  language     = {eng},
  number       = {4},
  pages        = {256--257},
  publisher    = {Federation of European Neuroscience Societies and Blackwell Publishing Ltd},
  series       = {Vox Sanguinis},
  title        = {The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies},
  url          = {http://dx.doi.org/10.1046/j.1423-0410.2000.78402561.x},
  doi          = {10.1046/j.1423-0410.2000.78402561.x},
  volume       = {78},
  year         = {2000},
}